Loading the section…
The price of Benitec Biopharma Inc. (BNTC) on October 9, 2026 is 8.87 USD, +1.37% on the day. Over 52 weeks the stock traded between 8.52 USD and 16.76 USD; the price now sits 4% of the way up that range. Over the past year the price changed by −37.09%. Market capitalization is 304.72 million USD, rank 171 among 373 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: none scheduled in the next five weeks · Earnings calendar
Change over the period shown (line colour): −40.87 %
Benitec Biopharma Inc. trades on Nasdaq under the ticker BNTC. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks BNTC has traded between 8.52 $ and 16.76 $. As of 9 October 2026 the price stood 4.25 % of the way from the 52-week low to the high.
Over one year BNTC shares fell 37.09 %; over six months they fell 22.33 %. Volatility over 90 days is 55.16 %. Dividends are not included: this is price change only, as of 9 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 1.7, below the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 8.72 | 9.03 | 8.71 | 8.87 | 73,000 |
| 8 October 2026 | 8.86 | 8.97 | 8.61 | 8.75 | 234,900 |
| 7 October 2026 | 8.81 | 9.27 | 8.80 | 8.99 | 190,100 |
| 6 October 2026 | 9.32 | 9.57 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:3940 TRUST WAY, HAYWARD, CA, 94545, US
Benitec Biopharma Inc. reported revenue of 0 $ and a net loss of 42M $ over the last four quarters. Earnings per share are −0.93 $. Market capitalisation is 305M $.
BNTC has a return on equity of −22.66 %, above the sector median of −41.68 %. Return on assets is −22.21 %, above the sector median of −32.11 %.
| 1.2B |
| PFEPfizer, Inc. | 28.28 | +1.65 % | 922M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 8.62 |
| 9.00 |
| 217,200 |
| 5 October 2026 | 9.00 | 9.99 | 8.52 | 9.23 | 584,200 |
| 2 October 2026 | 9.71 | 9.88 | 8.92 | 8.98 | 135,100 |
| 1 October 2026 | 9.94 | 10.17 | 9.47 | 9.58 | 103,100 |
| 30 September 2026 | 9.83 | 10.13 | 9.64 | 10.00 | 146,000 |
| 29 September 2026 | 10.17 | 10.17 | 9.65 | 9.75 | 111,000 |
| 28 September 2026 | 9.57 | 10.04 | 9.31 | 10.02 | 152,800 |
| 25 September 2026 | 9.70 | 9.80 | 9.31 | 9.59 | 107,000 |
| 24 September 2026 | 9.74 | 10.41 | 9.26 | 9.64 | 196,700 |
| 23 September 2026 | 10.92 | 11.32 | 9.49 | 9.83 | 644,200 |
| 22 September 2026 | 10.97 | 11.37 | 10.61 | 10.95 | 88,900 |
| 21 September 2026 | 11.12 | 11.14 | 10.74 | 10.88 | 121,900 |
| 18 September 2026 | 11.37 | 11.62 | 10.86 | 11.02 | 423,000 |
| 17 September 2026 | 11.27 | 11.55 | 11.15 | 11.36 | 91,300 |
| 16 September 2026 | 11.09 | 11.45 | 10.89 | 11.04 | 138,800 |
| 15 September 2026 | 12.11 | 12.37 | 10.96 | 11.05 | 263,400 |
| 14 September 2026 | 12.24 | 12.42 | 12.01 | 12.08 | 106,400 |